Docoh
Loading...

LLY Lilly(Eli) & Co

Lilly is a global health care leader that unites caring with discovery to create medicines that make life better for people around the world. It was founded more than a century ago by a man committed to creating high-quality medicines that meet real needs, and today it remains true to that mission in all its work. Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism.

Company profile

Ticker
LLY
Exchange
Website
CEO
David Ricks
Employees
Incorporated
Location
Fiscal year end
Former names
LILLY ELI & CO, LILLY ELI & CO ET AL
SEC CIK
IRS number
350470950

LLY stock data

(
)

Calendar

3 Aug 21
4 Aug 21
31 Dec 21
Quarter (USD)
Jun 21 Mar 21 Dec 20 Sep 20
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Annual (USD)
Dec 20 Dec 19 Dec 18 Dec 17
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Financial data from company earnings reports.

Date Owner Security Transaction Code Indirect 10b5-1 $Price #Shares $Value #Remaining
21 Jul 21 Lilly Endowment Common Stock Sell Dispose S No No 237 86,111 20.41M 108,762,100
20 Jul 21 Lilly Endowment Common Stock Sell Dispose S No No 237.055 15,610 3.7M 108,848,211
19 Jul 21 Kimberly H Johnson Common Stock Grant Aquire A No No 234.14 41 9.6K 235
19 Jul 21 Tai Jackson P Common Stock Grant Aquire A No No 234.14 8 1.87K 61,274
19 Jul 21 Alvarez Ralph Common Stock Grant Aquire A No No 234.14 47 11K 49,849

Data for the last complete 13F reporting period. To see the most recent changes to ownership, click the ownership history button above.

70.1% owned by funds/institutions
13F holders
Current Prev Q Change
Total holders 1899 1848 +2.8%
Opened positions 176 243 -27.6%
Closed positions 125 132 -5.3%
Increased positions 653 640 +2.0%
Reduced positions 752 660 +13.9%
13F shares
Current Prev Q Change
Total value 125.32B 132.62B -5.5%
Total shares 671.87M 785.58M -14.5%
Total puts 5.42M 4.46M +21.5%
Total calls 4.33M 4.41M -1.8%
Total put/call ratio 1.3 1.0 +23.6%
Largest owners
Shares Value Change
Vanguard 69.29M $12.94B +0.9%
BLK Blackrock 59.07M $11.04B +0.4%
PNC PNC Financial Services 52.21M $9.75B -0.2%
Primecap Management 35.38M $6.61B -3.8%
STT State Street 32.51M $6.07B -2.9%
Wellington Management 31.79M $5.94B -4.1%
FMR 30.85M $5.76B +20.4%
TROW T. Rowe Price 26.16M $4.89B +116.3%
State Farm Mutual Automobile Insurance 18.62M $3.48B 0.0%
JPM JPMorgan Chase & Co. 17.33M $3.24B -19.4%
Largest transactions
Shares Bought/sold Change
Lilly Endowment 0 -111.13M EXIT
TROW T. Rowe Price 26.16M +14.06M +116.3%
Capital World Investors 14.6M +11.75M +411.7%
Norges Bank 0 -8.67M EXIT
FMR 30.85M +5.22M +20.4%
JPM JPMorgan Chase & Co. 17.33M -4.18M -19.4%
Jennison Associates 5.44M +3.56M +189.5%
Capital International Investors 8.89M -2.48M -21.8%
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main 486.57K -2.09M -81.1%
Citadel Advisors 111.68K -2.01M -94.7%

Financial report summary

?
Management Discussion
  • Item 2. Management’s Discussion and Analysis of Results of Operations and Financial Condition
Content analysis
?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
H.S. freshman Avg
New words: admissibility, admitting, Alpha, Appellate, AstraZeneca, authorisation, bebtelovimab, Branchburg, broadened, Chancery, circulation, contrary, core, Delta, destocking, Division, dominant, Economy, EO, ESI, expiry, fact, Fee, Gamma, GGG, hearing, interlocutory, Kumquat, letter, lien, LP, Miami, MiNA, Mosaic, notified, pathway, premium, preserved, Protomer, refractory, restraining, resurgent, Rome, shipment, site, stimulate, strong, temporary, unchanged, User, variant, Vienna, Western, withdrawn
Removed: agreed, finally, growth, Notwithstanding, protracted, quickly, remove, resolved, sheet, transition, ultimate, valid